Press

FILTER:

Micro-3D Printing Powers Cancer Organoid Research

Advances in cancer research increasingly depend on the ability to replicate the body's complex biology at a microscale. Join John Kawola, CEO of BMF, as he explores the role of 3D printing in organoid and cancer research.

Replacing Animal Testing with Organoids

Newly-installed FDA Commissioner Marty Makary announced a plan to begin phasing out animal testing in drug development, particularly for monoclonal antibodies, but how long will it take?

The Trade War Is On. Is This 3-D Printing’s Moment?

What if, instead of buying your parts from abroad, there was a simpler way to manufacture at home without building a factory. That’s the solution seen by advocates of additive manufacturing, more colloquially known as 3-D printing. Instead of buying parts from a foreign country, additive enthusiasts ask, why not print them in the U.S.?

Boston Globe Media’s New England’s Fastest Growing Companies 2025

We’re proud to have been named to Boston Globe Media's New England’s Fastest Growing Companies 2025! It’s great to represent the 3D printing space as we continue to work to enable innovation across industries. Here’s to our fellow New Englanders on this list – congratulations!

3D Printing Industry -Executive Survey

Our CEO John Kawola is in good company in 3D Printing Industry’s 2025 Executive Survey, sharing his thoughts on the future of 3D printing and how AI will impact additive manufacturing. As our industry continues to evolve, John sees an expanded need for materials compatibility in the short term and how 3D printing is uniquely positioned to solve society’s big problems in the long term.

Three Predictions for High-Precision 3D Printing and Innovation

Steady customer growth, new materials and applications, U.S. Food and Drug Administration (FDA) 510(k) clearance for innovative UltraThineer™ material, commercialization in global dental markets and industry’s first line of hybrid micro 3D printers fueled growth in 2024.